EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Analysis of pathogens and susceptibility in cancer patients with febrile neutropenia and bacteremia Experience in a single institution in eastern Taiwan



Analysis of pathogens and susceptibility in cancer patients with febrile neutropenia and bacteremia Experience in a single institution in eastern Taiwan



Tzu Chi Medical Journal 23(4): 115-118



Febrile neutropenia is a major complication in patients with malignancies receiving chemotherapy. The pathogens vary in different geographic areas, however, and also may vary in different institutions. This retrospective study analyzed the profile of bacteria in cases of febrile neutropenia at a single medical center in eastern Taiwan.Materials From July 26 to July 27, we retrospectively evaluated 8 adult cancer patients who were admitted to the hematology and oncology ward in our hospital because of febrile neutropenia. The clinical characteristics of those who survived (survival group) and those who died (mortality group) were compared. The blood culture data and susceptibility to antibiotics during episodes of febrile neutropenia were obtained for interpretation. Among a total of 11 episodes of febrile neutropenia, 31% had documented bacteremia. The most common malignancy among these patients was acute leukemia (31%), followed by non-Hodgkin s lymphoma and breast cancer. The median time from the start of chemotherapy to febrile neutropenia was shorter in the mortality group than the survival group (8.5 days vs. 11 days;p = .46). The rate of positive blood cultures was much higher in those who died compared to those who survived (75% vs. 23%,p = .1). Gram-negative bacilli were the predominant pathogens in these neutropenic patients, which is different from the trend in Western countries. Infection withEscherichia coliwas more common in the survival group andPseudomonasspecies were more common in the non-survival group. Gram-positive cocci occurred in similar proportions in both groups. E coliin patients with febrile neutropenia were still susceptible to all first-line antibiotics. Adult cancer patients with febrile neutropenia are at a high risk of mortality, especially those with documented bacteremia and short times between chemotherapy and neutropenia. Gram-negative bacilli are still the predominant pathogens in patients with febrile neutropenia and most are still susceptible to all first-line antibiotics. Further investigation into the relationship between the patterns of different pathogens and mortality in this population is needed.

(PDF emailed within 0-6 h: $19.90)

Accession: 036244541

Download citation: RISBibTeXText

DOI: 10.1016/j.tcmj.2011.09.002



Related references

Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution. Journal of Community and Supportive Oncology 12(9): 312-320, 2015

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns. Supportive Care in Cancer 21(9): 2417-2426, 2014

Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan. Journal of Microbiology, Immunology, and Infection 36(3): 197-202, 2003

The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Israel Medical Association Journal 9(6): 424-429, 2007

Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia. Future Microbiology 10(3): 357-364, 2016

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia. Clinical Infectious Diseases 29(3): 495-502, 1999

Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. Journal of Geriatric Oncology 4(2): 190-195, 2013

Trends in spectrum and susceptibility patterns of pathogens causing bacteremia in pediatric febrile neutropenic oncologic patients. International Journal of Infectious Diseases 6(Supplement 2): 2S28-2S31, June, 2002

Oral Cefixime in the management of febrile neutropenic children with cancer and lower-risk of bacteremia A single institution study in Argentina. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 592, 1998

Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis. Journal of Oncology 2015: 596504-596504, 2015

Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of Turkey. Indian Journal of Microbiology 52(2): 203-208, 2013

The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Research and Treatment 43(3): 176-180, 2011

Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study. American Journal of Infection Control 42(1): 74-76, 2014

Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Supportive Care in Cancer 11(5): 332-335, 2003

Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatric Infectious Disease Journal 10(7): 506-510, 1991